Use of cc-chemokine mutants against liver diseases

Details Use of cc-chemokine mutants against liver diseases Use of cc-chemokine mutants against liver diseases

A - Human Necessities

61

K

A61K 38/19 (2006.01) A61P 1/16 (2006.01)

Patent

CA 2507008

CC-chemokine mutants having reduced Glycosaminoglycans (GAG)-binding properties are effective against liver fibrotic inflammatory and/or autoimmune diseases. Particularly preferred are the mutants of CCL5/RANTES having reduced GAG-binding properties.

La présente invention a trait à des mutants de la CC-chimiokine présentant des propriétés réduites de liaison aux glycosaminoglycanes (GAG) efficaces contre les maladies inflammatoires fibreuses et/ou auto-immunes du foie. Les mutants particulièrement préférés sont les CCL5/RANTES présentant des propriétés réduites de liaison

Affiliated with

Also associated with

Rating

Use of cc-chemokine mutants against liver diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of cc-chemokine mutants against liver diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cc-chemokine mutants against liver diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2050921